Surgery Partners, INC

Surgery Partners announced an agreement to sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for approximately $795 million.

Surgery Partners, Inc. announced the results of its Annual Meeting, confirming the re-election of Class II directors and the approval of executive compensation and auditor ratification.

Surgery Partners announced its first quarter 2026 financial results, reporting a 4.5% increase in revenue and reaffirming its full-year guidance.

Surgery Partners, Inc. announced mixed fourth quarter and full year 2025 results, including a net loss, but provided 2026 guidance and authorized a $200 million share repurchase program.

Surgery Center Holdings, a wholly-owned subsidiary of Surgery Partners, Inc., has issued an additional $425 million in 7.250% Senior Notes due 2032.

Surgery Partners' subsidiary, Surgery Center Holdings, Inc., priced a $425 million offering of 7.250% senior unsecured notes due 2032, with proceeds intended for general corporate purposes and debt repayment.

Surgery Partners reported a 4.5% increase in Q1 2026 revenue to $810.9 million, driven by same-facility growth, though net loss attributable to the company widened to $35.9 million.

Surgery Partners, Inc. reported a 6.6% increase in third-quarter revenues to $821.5 million, alongside an improved net loss of $22.7 million, though interest expenses rose significantly.

Surgery Partners, Inc. reported an 8.3% revenue increase and reduced Q2 net loss, but saw a higher net loss and decreased operating cash flow for the first six months of 2025.

Surgery Partners' Q1 2025 revenue increased by 8.2%, but the net loss attributable to the company widened to $37.7 million.

Surgery Partners saw a revenue increase of 14.3% in the third quarter of 2024, but also experienced a net loss attributable to Surgery Partners, Inc. of $31.7 million.

Surgery Partners' second quarter saw revenue growth driven by same-facility performance and acquisitions, but a net loss was reported due to increased expenses and debt extinguishment costs.

Surgery Partners, Inc. reported a significant reduction in net loss and growth in revenue and Adjusted EBITDA for the fiscal year ended December 31, 2025, driven by same-facility performance and strategic acquisitions.

Surgery Partners, Inc. reports a 13.5% increase in revenue and a 16.0% increase in Adjusted EBITDA for 2024, but also a net loss attributable to Surgery Partners, Inc. of $168.1 million.

Surgery Partners, Inc. reports an 8% increase in revenue and a net loss of $11.9 million for the full year 2023, according to its 10-K filing.

Blair E Hendrix, a Director of Surgery Partners, Inc., received 34,364 shares of common stock on June 18, 2026.

Director Blair E. Hendrix acquired 11,670 shares of Surgery Partners, Inc. common stock on June 5, 2026.

John A. Deane, a Director at Surgery Partners, Inc., has acquired 11,670 shares of common stock.

Laura L. Forese, a Director at Surgery Partners, Inc., acquired 11,670 shares of common stock on June 5, 2026, with vesting scheduled for June 5, 2027.

Surgery Partners, Inc. Director Clifford G. Adlerz acquired 11,670 shares of common stock on June 5, 2026, at a price of $13.71 per share.

Surgery Partners, Inc. reports a director's acquisition of 11,670 common shares.

Surgery Partners, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 5, 2026, with April 8, 2026, as the record date for voting eligibility.

Surgery Partners, Inc. has filed a definitive proxy statement with the SEC.

Surgery Partners is asking stockholders to approve the 2025 Omnibus Incentive Plan to replace the expiring 2015 plan and continue offering equity-based incentives.

Surgery Partners, Inc. has filed a definitive proxy statement with the SEC.

Surgery Partners, Inc. announces its 2024 annual meeting of stockholders to be held virtually on June 6, 2024, outlining proposals for director elections, executive compensation, and an employee stock purchase plan.

Bain Capital entities have withdrawn their non-binding proposal to acquire all outstanding shares of Surgery Partners, Inc. they do not already own, following feedback from the Issuer's Independent Committee.

Bain Capital Private Equity, a significant shareholder in Surgery Partners, Inc., has submitted a non-binding proposal to acquire all outstanding shares it does not already own for $25.75 per share in cash.

FMR LLC, through its subsidiaries, has reported beneficial ownership of 2,191,465.08 shares of Surgery Partners Inc. common stock, representing 1.7% of the class.

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Surgery Partners Inc. following an internal corporate realignment.

FMR LLC and its affiliates, including Abigail P. Johnson, reported a continued 5.1% beneficial ownership stake in Surgery Partners Inc. as of December 31, 2025.

Pentwater Capital Management LP and Matthew Halbower have disclosed a 9.1% beneficial ownership stake in Surgery Partners, Inc., totaling 11,681,000 shares.

Janus Henderson Group plc and its affiliates reported a beneficial ownership of 10.2% in Surgery Partners, Inc. common stock as of September 30, 2025.

King Street Capital Management and its affiliates have reported a 7.2% beneficial ownership stake in Surgery Partners, Inc., holding 9,339,930 shares of common stock.